Kuaishou Technology to Report 2026 Third Quarter Financial Results on November 19, 2026
PR Newswire
Today at 8:47am UTC
Mojo Pitching Coach Adds 12 AI Personas for Agent Practice
Press Services
Today at 8:20am UTC
Broadridge's Distributed Ledger Repo Processes $7.6 Trillion in October
PR Newswire
Today at 7:00am UTC
Transferable Value Index: 1 in 6 Durable Businesses Still Runs Through Its Owner
Press Services
Today at 7:00am UTC
DSA’s Adrian Wall and Former CFTC Chair Chris Giancarlo Discuss Future of U.S. Crypto Regulation at Strobe Summit
EasyPR News
Today at 6:59am UTC
IUX Officially Launches New Credit Campaign Offering Up to $1,500 in Trading Credits
NewsDirect
Today at 6:45am UTC
Fermi's Co-Founder and Largest Shareholder, Toby Neugebauer: "Fermi's Shareholders, the Markets and Texas Voters Have Rejected Rick Perry...
PR Newswire
Today at 4:42am UTC
INOVIO Announces Pricing of Approximately $75 Million Public Offering
PR Newswire
Today at 4:18am UTC
Gate Pioneers Proof of Security (PoSEC), Achieving 104.58% Cold Storage Coverage to Solidify Asset Security
EasyPR News
Today at 3:54am UTC
SM Investments earns third consecutive Five Golden Arrow Award
PR Newswire
Today at 3:03am UTC
OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Anticancer Hospital of Thessaloniki
PRLog
Today at 3:00am UTC
Hanon Systems Announces Third Quarter 2026 Financial Results
PR Newswire
Today at 2:41am UTC
Phase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine
PR Newswire
Today at 2:27am UTC
Titan FX Strengthens Growth Capabilities with Senior APAC Appointments and Unified Team
NewsDirect
Today at 2:26am UTC
Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted...
PR Newswire
Today at 2:03am UTC
Coway Announces Financial Results for Q3 FY2026
PR Newswire
Today at 1:00am UTC
Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal
PR Newswire
Today at 1:00am UTC
Antengene Announces First Patient Dosed in Phase I ATTRACT Study Evaluating ATG-201 (CD19 × CD3 TCE) for B Cell-Mediated Autoimmune Diseases
PR Newswire
Today at 12:30am UTC
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and...
PR Newswire
Today at 12:00am UTC
A-Z Supply: Bloomfield NJ Dispensary Open 9 AM-10 PM Daily
Press Services
Yesterday at 11:51pm UTC
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 19
  • 20
  • >
Skip to content
StockOptionNews
  • Home
  • Stocks
  • Market TV
  • Press Releases
  • Glossary
StockOptionNews

News
  • Major News
  • Analyst Ratings
  • Price Targets
  • Financial Reports
Markets
  • Stocks
  • Market TV
  • Glossary
Company
  • About Us
  • Contact Us
  • Terms
  • Privacy
© 2026 StockOptionNews. All rights reserved.